Primary T‐cell‐based delivery platform for in vivo synthesis of engineered proteins
Abstract Primary T cell has been transformed into a cell‐based delivery platform that synthesizes complex biologics at the disease site with spatiotemporal resolution. This broadly applicable technology can circumvent toxicities due to systemic administration of biologics that necessitates the use o...
Saved in:
Main Authors: | Harikrishnan Radhakrishnan (Author), Sherri L. Newmyer (Author), Marvin A. Ssemadaali (Author), Harold S. Javitz (Author), Parijat Bhatnagar (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Electrically regulated cell‐based intervention for viral infections
by: Sherri Newmyer, et al.
Published: (2023) -
Genetically engineered pair of cells for serological testing and its application for SARS‐CoV‐2
by: Marvin A. Ssemadaali, et al.
Published: (2023) -
Mimicking the Biology of Engineered Protein and mRNA Nanoparticle Delivery Using a Versatile Microfluidic Platform
by: Valentina Palacio-Castañeda, et al.
Published: (2021) -
Engineered platelets-based drug delivery platform for targeted thrombolysis
by: Songli Wang, et al.
Published: (2022) -
Engineering of a novel optimized platform for sublingual delivery with novel characterization tools: in vitro evaluation and in vivo pharmacokinetics study in human
by: Nadia M. Morsi, et al.
Published: (2017)